Evaluation of Patients With Lupus Nephritis Using Kidney MRI (Magnetic Resonance Imaging)
NCT06445127 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 15
Last updated 2025-05-07
Summary
This study is being done to find out if a non-invasive Magnetic Resonance Imaging (MRI) examination of the kidneys may be helpful in patients with systemic lupus erythematosus (SLE).
Conditions
- SLE (Systemic Lupus)
Sponsors & Collaborators
-
Janssen Scientific Affairs, LLC
collaborator INDUSTRY - lead OTHER
Principal Investigators
-
Homa Timlin, MD, MSc, MRCP, CCST · Johns Hopkins School of Medicine
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-05-07
- Primary Completion
- 2025-01-01
- Completion
- 2025-04-08
Countries
- United States
Study Locations
More Related Trials
-
Autologous Hematopoietic Stem Cell Transplantation for Refractory Lupus Nephritis
NCT03828071 ·Status: COMPLETED ·Phase: NA
-
Disease Activity Biomarkers in Patients With Systemic Lupus Erythematosus
NCT05443516 ·Status: RECRUITING
-
Per-protocol Repeat Kidney Biopsy in Incident Cases of Lupus Nephritis
NCT04449991 ·Status: RECRUITING ·Phase: NA
-
Renal Survival in Patients with Lupus Nephritis
NCT06588192 ·Status: NOT_YET_RECRUITING
-
Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus Nephritis
NCT01541670 ·Status: TERMINATED ·Phase: PHASE1
-
Predictors of Remission and Renal Outcomes in Lupus Nephritis in Assuit University Hospitals.
NCT06228222 ·Status: NOT_YET_RECRUITING
-
Study of Systemic Lupus Erythematosus
NCT00001372 ·Status: RECRUITING
-
T Regulatory Cells IN LUPUS NEPHRITIS
NCT06428539 ·Status: NOT_YET_RECRUITING
-
Open Label Pilot Trial of Rituximab in Lupus Membranous Nephritis
NCT00908986 ·Status: WITHDRAWN ·Phase: NA
-
Fixed-dose Versus Concentration-controlled Mycophenolate Mofetil for the Treatment of Active Lupus Nephritis
NCT03920059 ·Status: TERMINATED ·Phase: PHASE4
-
Exploring Biomarkers for Therapeutic Response of Lupus Nephritis Based on Multi Omics Analysis
NCT06167174 ·Status: RECRUITING
-
The Efficacy and Safety of Telitacicept and Belimumab in Active Lupus Nephritis in the Real World: a Prospective Cohort Study
NCT05588830 ·Status: UNKNOWN
-
Concentration-controlled Therapy of Mycophenolate Mofetil (MMF) in Proliferative Lupus Nephritis
NCT01042457 ·Status: COMPLETED ·Phase: PHASE3
-
Prediction of Outcome of Lupus Nephritis
NCT02403115 ·Status: UNKNOWN
-
Mycophenolic Acid Pharmacokinetics and Pharmacogenomics in Lupus Nephritis
NCT02453997 ·Status: COMPLETED
-
Positron Emission Tomography (PET) to Locate Areas of White Blood Cell Activity
NCT00029926 ·Status: COMPLETED
-
Evaluation of Janus Kinase_3 in Juvenile Onset Systemic Lupus Erythematosus
NCT04293510 ·Status: UNKNOWN
-
Comparison of the Efficacy of Two Rituximab Treatment Regimens in Patients With Lupus Nephropathy
NCT01765842 ·Status: TERMINATED ·Phase: PHASE3
-
Renal Resistive Index as a Marker of Severity and Treatment Outcomes in Lupus Nephritis
NCT03958851 ·Status: UNKNOWN
-
A Study to Evaluate the Efficacy and Safety of Rituximab in Subjects With International Society of Nephrology/Renal Pathology Society (ISN/RPS) 2003 Class III or IV Lupus Nephritis
NCT00282347 ·Status: COMPLETED ·Phase: PHASE3
-
TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL )
NCT00368264 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Disease Progression and Activity in Patients With Systemic Lupus Erythematosus
NCT00339261 ·Status: COMPLETED
-
Lupus Landmark Study: A Prospective Registry and Biorepository
NCT05934149 ·Status: RECRUITING
-
SSerum/Urinary Monocyte Chemoattractant Protein-1 Level as a Marker for Lupus Nephritis
NCT03164720 ·Status: UNKNOWN
-
A Study to Evaluate the Safety and Efficacy of Obinutuzumab Compared With Placebo in Participants With Lupus Nephritis (LN)
NCT02550652 ·Status: COMPLETED ·Phase: PHASE2